The study, appearing in the society’s journal, GIE: Gastrointestinal Endoscopy, found that a patient detected with the new screening protocol was alive without evidence of recurrence three years after surgical resection.
The study said costs of the new screening protocol were acceptable: $8,431 to detect pancreatic neoplasia and $41,133 to detect pancreatic cancer.
Read the American Society for Gastrointestinal Endoscopy release on pancreatic cancer detection (pdf).
Related Articles on Pancreatic Cancer:
Expert Cautions Findings on Pancreatic Cancer Screening
New Research Supports Previous Studies Aspirin Reduces Risk of CRC
Study: Endoscopic Ultrasound Associated With Improved Pancreatic Cancer Outcomes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
